Synergistic Tissue Ablation Systems

The inventive concept integrates pulse shape designs for tissue ablation with AI, IoT, blockchain, and nanomaterial technologies to create a more powerful, personalized, and secure system for minimally invasive tissue ablation.

The original patent disclosed methods, systems, and apparatuses for tissue ablation using pulse shape designs, but was limited to a standalone electrolysis-based approach. The new inventive concept addresses the limitations of the original patent by incorporating distinct technologies to enhance treatment efficacy, patient outcomes, and data management.

The synergistic tissue ablation system comprises a pulse generator configured to deliver a pulse of a current or a voltage to a treatment site, with a falling edge that comprises an exponential decay. The system integrates AI-powered machine learning algorithms to analyze patient data and generate customized pulse shape designs. An IoT-enabled ablation device delivers the customized pulse to the treatment site. A blockchain-based data storage unit records treatment data and tracks patient outcomes, ensuring secure and transparent data management. A nanomaterial-based sensor unit provides real-time monitoring of treatment efficacy. The system also includes a cloud-based analytics platform for analyzing treatment data and providing predictive insights for personalized medicine.

The new claims introduce the integration of AI, IoT, blockchain, and nanomaterial technologies with pulse shape designs for tissue ablation, which is not obvious from the original patent. The inventive concept's synergistic combination of these technologies provides a new and non-obvious solution for tissue ablation.

Alternative embodiments may include using different AI algorithms or machine learning models to generate customized pulse shape designs. Variations of the system may incorporate additional technologies, such as augmented reality or robotic-assisted surgery, to further enhance treatment outcomes.

The synergistic tissue ablation system has commercial potential in the medical device industry, particularly in the fields of oncology, cardiology, and neurology. The system's ability to provide personalized and secure treatment options may attract significant market share and revenue growth.